The federal agency wants to see records showing how a select group of willing patients responded to receiving a drug versus a placebo to confirm that its safe for patients with specific conditions to take it
In the multivariate analysis, l-carnitine administration (odds ratio [OR] 3.51, 95% confidence interval [CI] 1.239.99, p = 0.019) and baseline NIRS data of 0.07 mMmm (OR 5.21, 95% CI 1.6916.0, p = 0.0041) were found as independent significant factors
Potential Side Effects Like any medical treatment, GLP-1 therapy has potential side effects that patients should be aware of
Nonetheless, because it has the active ingredient semaglutide, many medical providers prescribe it off-label to help obese individuals lose fat
A physician asked me to see his patient, a middle-aged woman who was using an insulin pen
Works as described lost 10-15 pounds so far Excellent, plan to use again